Skip to main content
Investing

Measuring the impact of anti-obesity drugs

The next wave of GLP-1 treatments will do more than just shrink waistlines - Pictet Asset Management. With an estimated one in eight Americans having taken weight loss drugs such as Ozempic in the past two years, their widespread use could bring considerable economic benefits…
EFI
21 March 2025
Investing

Mr Trump’s tariff machine gun and Mr Merz’s fiscal bazooka

Bruno Cavalier, Chief Economist ODDO BHF Asset Management. KEY HIGHLIGHTS: Donald Trump launched a tariff war earlier and more aggressively than during his first term. This has led to economic instability which has lowered household and market confidence The US economy is likely to slow…
EFI
21 March 2025
Investing

Wind of Change

By Laurent Denize Global Co-CIO ODDO BHF. "As unpredictability has become Donald Trump's defining characteristic, volatility will be a continuing feature of his presidency The good news is that the wind can also change direction violently (but positively this time) for other geographies such as…
EFI
20 March 2025
Investing

Not so exceptional

Stagflation fears César Pérez Ruiz, Chief Investments Officer Pictet Wealth Management. Stock markets fell last week, and volatility surged on uncertainty over President Trump’s tariff and cost-cutting measures. A deteriorating economic picture in the US added to the unease, with stagflation fears fuelled by signs that…
EFI
20 March 2025
Investing

Battle stations!

Clément Inbona, Fund Manager, La Financière de l’Échiquier. Forget the Magnificent Seven, that exclusive club of US mega-stocks linked, in particular, to the tech and AI sectors. The new stock market darlings are “Le(s) S.T.A.R.S” – Leonardo, Saab, Thales, Airbus, Rheinmetall and Safran. These six…
EFI
20 March 2025